Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood
A phase 1/2 trial of Quizartinib, Fludarabine, Cytarabine and Etoposide in acute myeloid leukaemia, run by Daiichi Sankyo, active and no longer recruiting.
Overview
Safety and Efficacy of Quizartinib in Children and Young Adults With Acute Myeloid Leukemia (AML), a Cancer of the Blood is a phase 1/2 interventional study registered as NCT03793478 by Daiichi Sankyo, with 65 participants enrolled, started 2018-08-15 and due to reach its primary completion in 2027-05-01. Interventions recorded: Quizartinib, Fludarabine, Cytarabine, Intrathecal (IT) triple chemotherapy prophylaxis and Etoposide.
Similar pages
not linked directly; found by shared links- TrialEvaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Shares Quizartinib, Daiichi Sankyo, Acute myeloid leukaemia and the tag pipeline.
- TrialA Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) Mutation
Shares Cytarabine, Fludarabine, Etoposide, Acute myeloid leukaemia and the tag pipeline.
- TrialA Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML
Shares Cytarabine, Fludarabine, Acute myeloid leukaemia and the tag pipeline.
- TrialA Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia
Shares Cytarabine, Acute myeloid leukaemia and the tag pipeline.
- TrialGalinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2
Shares Cytarabine, Acute myeloid leukaemia and the tag pipeline.
- TrialClinical Study of ARD103 CAR-T Therapy for Patients With R/R AML or MDS
Shares Fludarabine, Acute myeloid leukaemia and the tag pipeline.
- TrialStudies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Shares Cytarabine, Acute myeloid leukaemia and the tag pipeline.
- TrialPharmacogenomics ANDA SNP Clinical Study - Etoposide and Single Nucleotide Polymorphisms
Shares Etoposide and the tag pipeline.